Vaccine registration process will soon begin for 25.53 lakh children of Odisha in the 15-18 years age group. During the next vaccination drive, precautionary dose will be administered to over 7 lakh frontline workers and elderly persons with co-morbidities. Vaccination drive is underway at 200 stations, and if required, schools and colleges will be designated as vaccine centres, informed state health and family welfare director Bijay Panigrahi. Further, he said that eight mobile teams have been deployed in each block of Odisha. What’s concerning is 29 lakh beneficiaries in the state are yet to take the first dose of Covid vaccine.
The team proposed a deep learning-based algorithm called COMiT-Net, which learns the abnormalities present in the chest X-Ray images to differentiate between a Covid affected lung and a non-Covid affected lung.
Bharat Biotech has received approval from the Drug Controller General of India to conduct phase-3 trials for its COVID-19 intra-nasal vaccine (BBV154), sources in the company said on Friday.
The new test card which has been developed under the collaboration of RMRC and IMGENEX India Pvt. Ltd, Bhubaneswar will be available in the market within two months, informed Dr. Sujay Singh, CEO, IMGENEX.
According to the Central government's CoWIN portal, a total 1,02,90,374 precaution doses have been administered among frontline workers, healthcare workers and people above 60 years of age so far
The team proposed a deep learning-based algorithm called COMiT-Net, which learns the abnormalities present in the chest X-Ray images to differentiate between a Covid affected lung and a non-Covid affected lung.
Bharat Biotech has received approval from the Drug Controller General of India to conduct phase-3 trials for its COVID-19 intra-nasal vaccine (BBV154), sources in the company said on Friday.
LIVE TV
India
